699 related articles for article (PubMed ID: 34809540)
21. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
Kim H; Beack S; Han S; Shin M; Lee T; Park Y; Kim KS; Yetisen AK; Yun SH; Kwon W; Hahn SK
Adv Mater; 2018 Mar; 30(10):. PubMed ID: 29363198
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases.
Wu Y; Vazquez-Prada KX; Liu Y; Whittaker AK; Zhang R; Ta HT
Nanotheranostics; 2021; 5(4):499-514. PubMed ID: 34367883
[TBL] [Abstract][Full Text] [Related]
23. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
24. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
25. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
26. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
27. Carbon nanomaterials as versatile platforms for theranostic applications.
Kim M; Jang J; Cha C
Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
[TBL] [Abstract][Full Text] [Related]
28. Magnetic nanoemulsions as candidates for Alzheimer's disease dual imaging theranostics.
Antonoglou O; Giannousi K; Mourdikoudis S; Dendrinou-Samara C
Nanotechnology; 2020 Nov; 31(46):465702. PubMed ID: 32750688
[TBL] [Abstract][Full Text] [Related]
29. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle theranostics in cardiovascular inflammation.
MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
[TBL] [Abstract][Full Text] [Related]
31. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
[TBL] [Abstract][Full Text] [Related]
32. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
33. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
34. Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease.
Soursou G; Alexiou A; Ashraf GM; Siyal AA; Mushtaq G; Kamal MA
Curr Drug Metab; 2015; 16(8):705-12. PubMed ID: 26560322
[TBL] [Abstract][Full Text] [Related]
35. Applications of Nanoparticles in Alzheimer's Disease.
Liu Y; Shen Y
J Alzheimers Dis; 2023; 96(2):459-471. PubMed ID: 37807779
[TBL] [Abstract][Full Text] [Related]
36. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
[TBL] [Abstract][Full Text] [Related]
37. Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics.
Fang W; Su D; Lu W; Wang N; Mao R; Chen Y; Ge K; Shen A; Hu R
Curr Drug Targets; 2021; 22(8):913-921. PubMed ID: 33504304
[TBL] [Abstract][Full Text] [Related]
38. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
39. Current status of Cancer Nanotheranostics: Emerging strategies for cancer management.
Chavda VP; Khadela A; Shah Y; Postwala H; Balar P; Vora L
Nanotheranostics; 2023; 7(4):368-379. PubMed ID: 37151802
[TBL] [Abstract][Full Text] [Related]
40. Magnetic Nanoparticles in Cancer Theranostics.
Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
